Globe Pulsed Field System
Kardium, Inc. · Decision date Aug 27, 2025
What did the FDA approve?
FDA records P240044 as an original PMA application. The recorded decision is approval, dated Aug 27, 2025.
FDA approval order statement
approval for the Globe Pulsed Field System. This device is indicated for: The Globe Catheter is indicated for anatomical and electrophysiological mapping and stimulation of cardiac tissue, and for the delivery of ablation energy for the treatment of drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation, when used in conjunction with the Globe Pulsed Field System. The Globe PF System is indicated for catheter-based cardiac anatomical and electrophysiological mapping and stimulation of cardiac tissue.When used for pulsed field ablation, refer to the Instructions for Use of the compatible cardiac ablation catheter for the specific indications for use.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 27, 2025
Regulatory record facts
- Identifier
- P240044
- Regulatory pathway
- Premarket approval application
- Applicant
- Kardium, Inc.
- Product code
- QZI
- Decision code
- APPR
- Decision date
- Aug 27, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation.
- Applicant
- Kardium, Inc.
- Product code
- QZI
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P240044 received
Application receipt date recorded by FDA.
P240044 · FDA decision
APPR
P240044/S008 · Related supplement
Globe Pulsed Field System; Globe Catheter
P240044/S007 · Related supplement
Globe Catheter and Globe Pulsed Field System
Timeline entries are records held by MedtechLedger for P240044. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240044
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Globe Pulsed Field System; Globe CatheterP240044/S008 | Kardium, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Globe Catheter and Globe Pulsed Field SystemP240044/S007 | Kardium, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code QZI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Varipulse Bi-Directional CatheterP240006/S018 | Biosense Webster, Inc. | PMA supplement | Nov 3, 2026 | FDA |
Volt PFA SystemP250022/S002 | ABBOTT MEDICAL | PMA supplement | Oct 15, 2026 | FDA |
Affera Sphere-9 Mapping and Ablation CatheterP240013/S032 | Medtronic, Inc. | PMA supplement | Oct 9, 2026 | FDA |
Volt PFA Catheter, Sensor EnabledP250022/S009 | ABBOTT MEDICAL | PMA supplement | Oct 8, 2026 | FDA |
VOLT PFA CATHETER, SENSOR ENABLEDP250022/S012 | ABBOTT MEDICAL | PMA supplement | Oct 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Kardium, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 8518 Glenlyon Pkwy., Unit 155, Burnaby, V5J OB6
Sources and methodology
- Original FDA record: P240044
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
